slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 87,781-87,810
Pages 3,685
Rows per page 30
Component
87,781-87,810 of 110,539
01
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Attention1 hit
04
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The diagram uses a central hexagonal 'engine' connected to five key pillars, illustrating a value-chain or integrated platform approach.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations Loop · Golden Circle1 hit
10
Part of a corporate overview deck; highlights the financial structure of discovery partnerships.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations Beat · Business Model1 hit
12
This slide provides the definitions for the numbered references used in the preceding non-GAAP reconciliation tables.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · Appendix1 hit
07
Includes testimonials from KOLs to emphasize the difficulty of patient compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
08
The slide uses a pie chart to segment patients and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a biological process diagram showing intracellular vs plasma metabolism.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
11
The chart displays efficacy data for a drug candidate (pegtarviliase) across different dosage cohorts.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution Approach1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses a heatmap to display individual patient outcomes across four metrics (pArg, GMFM-E, 2MWT, GMFM-D).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
27
The slide includes experimental design details and statistical significance markers (p < 0.05).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
32
The chart is a box-and-whisker plot showing longitudinal data from baseline through 56 weeks.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
03
Aeva | Results Presentation Deck | 11 slidesAeva | Results Presentation Deck | 11 slides · Aeva
Conference presentation Investor relations 1 hit
11
USG = Underlying Sales Growth, UVG = Underlying Volume Growth, UPG = Underlying Price Growth.Unilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations Beat · KPI Overview1 hit
12
The chart shows a stacked bar decomposition of USG into UVG and UPG, with Q1'23 highlighted.Unilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations Beat · KPI Overview1 hit
13
USG = Underlying Sales Growth, UVG = Underlying Volume Growth, UPG = Underlying Price Growth.Unilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations Beat · KPI Overview1 hit
14
The chart shows a breakdown of USG (Underlying Sales Growth) into UVG (Underlying Volume Growth) and UPG (Underlying Price Growth) across five quarters.Unilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations Beat · KPI Overview1 hit
15
The chart uses a waterfall-style visualization to show the components of USG (Underlying Sales Growth) broken down into UVG (Underlying Volume Growth) and UPG (Underlying Price Growth).Unilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations Beat · KPI Overview1 hit
08
Waterfall chart shows the bridge from FY 2021 to FY 2022 revenues.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
09
The chart is a waterfall bridge showing the transition from 11.5% margin in 2021 to 10.6% in 2022.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
12
Includes disclaimer regarding non-IFRS financial measures.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Evidence1 hit
13
Includes a disclaimer regarding Non-IFRS financial measures.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Evidence1 hit
14
The slide explains a change in accounting/reporting methodology for corporate costs.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
18
Zegna | Results Presentation Deck | 36 slidesZegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Impact and Next StepsLoop · Golden Circle1 hit
19
The slide includes a disclaimer regarding the exclusion of the TOM FORD FASHION business from the targets.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Impact and Next StepsLoop · Golden Circle1 hit
32
This slide provides the granular breakdown of adjustments used to calculate non-IFRS financial measures for the Ermenegildo Zegna Group.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
33
The slide provides detailed accounting context for specific line items like 'other operating costs', 'write downs', and 'financial income' across different years and segments.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
35
Zegna | Results Presentation Deck | 36 slidesZegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit